Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

924
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
924
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

47
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
47
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Birth Control Methods01:22

Birth Control Methods

3.1K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
3.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

655
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
655

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular risk at menopause: The importance of a cardio-gynecological program.

Maturitas·2026
Same author

[A targeted approach to cardiovascular risk in women: towards improved screening and prevention].

Medecine sciences : M/S·2026
Same author

[Establishment of the Port-Royal menopause university center. Inform, screen, and provide care].

Medecine sciences : M/S·2026
Same author

[Menopause, hormone therapy and cardiovascular risk].

Medecine sciences : M/S·2026
Same author

Risk of cardiovascular disease and mortality among women with endometriosis: A systematic review and meta-analysis.

Acta obstetricia et gynecologica Scandinavica·2025
Same author

[Menopause: towards the end of a taboo?]

La Revue du praticien·2025

Related Experiment Video

Updated: Sep 18, 2025

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

2.0K

[Contraception and thrombophilia].

Geneviève Plu-Bureau1, Brigitte Raccah-Tebeka2

  • 1Service de gynécologie médicale, hôpital Cochin-Port-Royal, Paris ; Université Paris Cité, Paris, Inserm U1151, France.

La Revue Du Praticien
|June 23, 2025
PubMed
Summary
This summary is machine-generated.

Thrombophilia, a condition involving blood clotting abnormalities, requires careful consideration for contraception. Combined hormonal contraceptives and injectable progestin contraception are contraindicated for women with biological thrombophilia.

Keywords:
ContraceptionThrombophilia

More Related Videos

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

22.1K

Related Experiment Videos

Last Updated: Sep 18, 2025

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

2.0K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

22.1K

Area of Science:

  • Reproductive Health
  • Hematology
  • Pharmacology

Context:

  • Thrombophilia presents both biological (hemostasis anomaly) and clinical (family history) aspects.
  • Hormonal contraception use is common, necessitating risk assessment for venous thromboembolic events (VTE).

Purpose:

  • To clarify contraceptive recommendations for women with thrombophilia.
  • To guide healthcare providers in selecting safe and effective contraception for at-risk individuals.

Summary:

  • Systematic screening for biological thrombophilia before prescribing hormonal contraception is not recommended without a personal or family history due to cost-effectiveness concerns.
  • Combined hormonal contraceptives (oral, patch, ring) and injectable medroxyprogesterone acetate are contraindicated in women with biological thrombophilia.
  • Alternative contraceptive methods, including IUDs, progestin-only pills, and implants, are generally authorized for women with thrombophilia.

Impact:

  • Informs clinical practice regarding safe contraceptive choices for women with thrombophilia.
  • Aims to reduce the risk of venous thromboembolic events associated with certain contraceptive methods.
  • Promotes individualized patient care by outlining contraindications and authorized alternatives.